Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy
- PMID: 21296498
- PMCID: PMC3098951
- DOI: 10.1016/j.pain.2011.01.005
Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy
Abstract
Some expert guidelines recommend time-scheduled opioid dosing over pain-contingent dosing for patients receiving chronic opioid therapy (COT). The premise is that time-scheduled dosing results in more stable opioid blood levels and better pain relief, fewer adverse effects, less reinforcement of pain behaviors, and lower addiction risk. We report results of a survey of 1781 patients receiving COT for chronic noncancer pain, in which 967 reported time-scheduled opioid dosing only and 325 reported pain-contingent opioid dosing only. Opioid-related problems and concerns were assessed with the Prescribed Opioids Difficulties Scale. We hypothesized that respondents using time-scheduled opioid dosing would report significantly fewer problems and concerns than those using pain-contingent dosing. Patients receiving time-scheduled dosing received substantially higher average daily opioid doses than those using pain-contingent dosing (97.2 vs. 37.2mg average daily dose morphine equivalents, P < .0001). Contrary to expectation, time-scheduled opioid dosing was associated with higher levels of patient opioid control concerns than pain-contingent dosing (6.2 vs. 4.8, P=.008), after adjusting for patient and drug regimen differences. Opioid-related psychosocial problems were somewhat greater among patients using time-scheduled dosing, but this difference was nonsignificant after controlling for patient and drug regimen differences (5.9 vs. 5.0, P=.14). Time-scheduled dosing typically involved higher dosage levels and was associated with higher levels of patient concerns about opioid use. Controlled comparative effectiveness research is needed to assess benefits and risks of time-scheduled opioid dosing relative to pain-contingent opioid dosing among COT patients in ambulatory care. Patients with time-scheduled dosing received higher opioid dosage than patients with pain-contingent dosing. Time-scheduled dosing was associated with greater opioid control concerns than pain-contingent dosing.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest: Dr. Von Korff is principal investigator of a grant to Group Health Research Institute from Johnson and Johnson Inc. Dr. Sullivan has received grant support from Wyeth, Lilly, Aetna, Johnson & Johnson, and Ortho McNeil and has been a consultant for Eli Lilly.
Comment in
-
Opioids around the clock?Pain. 2011 Jun;152(6):1221-1222. doi: 10.1016/j.pain.2011.01.052. Epub 2011 Feb 10. Pain. 2011. PMID: 21315514 No abstract available.
Similar articles
-
Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain.Pain. 2010 May;149(2):345-353. doi: 10.1016/j.pain.2010.02.037. Epub 2010 Mar 23. Pain. 2010. PMID: 20334974 Free PMC article.
-
Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients.Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):581-7. doi: 10.1016/j.genhosppsych.2012.06.018. Epub 2012 Sep 5. Gen Hosp Psychiatry. 2012. PMID: 22959422 Free PMC article.
-
Efficacy and safety of scheduled dosing of opioid analgesics: a quality improvement study.J Pain. 2005 Oct;6(10):639-43. doi: 10.1016/j.jpain.2005.04.007. J Pain. 2005. PMID: 16202955
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?Pol Arch Med Wewn. 2009 Jul-Aug;119(7-8):469-77. Pol Arch Med Wewn. 2009. PMID: 19776687 Review.
Cited by
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
-
Pragmatic Opioid Use in Painful Diabetic Neuropathy.Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4. Eur Endocrinol. 2020. PMID: 32595765 Free PMC article. Review.
-
The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics.PLoS One. 2020 Apr 22;15(4):e0230751. doi: 10.1371/journal.pone.0230751. eCollection 2020. PLoS One. 2020. PMID: 32320421 Free PMC article.
-
Learning and Unlearning of Pain.Biomedicines. 2018 Jun 5;6(2):67. doi: 10.3390/biomedicines6020067. Biomedicines. 2018. PMID: 29874854 Free PMC article. Review.
-
Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients.J Pain Res. 2017 Jul 21;10:1713-1722. doi: 10.2147/JPR.S130913. eCollection 2017. J Pain Res. 2017. PMID: 28769587 Free PMC article.
References
-
- American Geriatrics Society. Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological Management of Persistent Pain in Older Persons. JAGS. 2009;57:1331–1346. - PubMed
-
- Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O’Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous